• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Rogers Corporation

Rogers Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Rogers Corporation Updates on Cost Improvement Initiatives

    Rogers Corporation Updates on Cost Improvement Initiatives

  2. Roche Presents Lab Solution at European Conference

    Roche Presents Lab Solution at European Conference

  3. Genentech’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer

    Genentech’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer

  4. Roche Considers Sale of Blood Glucose Meter Unit -Reuters

    Roche Considers Sale of Blood Glucose Meter Unit -Reuters

  5. Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO

    Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO

  6. FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mutation Test for Specific Type of Lung Cancer

    FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mutation Test for Specific Type of Lung Cancer

  7. Roche's Kadcyla Breast Cancer Drug Approved For Swiss Use

    Roche's Kadcyla Breast Cancer Drug Approved For Swiss Use

  8. Correction to FDA Medication Errors Warning Story

    Correction to FDA Medication Errors Warning Story

  9. FDA Warns Of Potential For Medication Errors With Two Breast Cancer Drugs

    FDA Warns Of Potential For Medication Errors With Two Breast Cancer Drugs

  10. Dodge & Cox: Pharma Stocks Showing Value

    As incomes rise, emerging-markets consumers can afford more and better medications driving attractive growth in the pharmaceuticals sector, say the managers of Dodge & Cox International Stock.

12
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.